Cargando…

Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis

BACKGROUND: Evaluation of costs and short-term cost-effectiveness of infliximab plus methotrexate (IFX + MTX); triple therapy of hydroxychloquine, sulphasalazine, and methotrexate (TRIPLE); or methotrexate monotherapy (MTX) in patients with new-onset polyarticular juvenile idiopathic arthritis (JIA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarkiainen, Maarit, Tynjälä, Pirjo, Vähäsalo, Paula, Aalto, Kristiina, Kröger, Liisa, Rebane, Katariina, Lahdenne, Pekka, Martikainen, Janne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670564/ https://www.ncbi.nlm.nih.gov/pubmed/36384562 http://dx.doi.org/10.1186/s12969-022-00748-w

Ejemplares similares

Health-related quality of life during early aggressive treatment in patients with polyarticular juvenile idiopathic arthritis: results from randomized controlled trial
por: Tarkiainen, Maarit, et al.
Publicado: (2019)

The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Lahdenne, Pekka, et al.
Publicado: (2018)

Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
por: Tarkiainen, M, et al.
Publicado: (2008)

Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study
por: Levälampi, Tiina, et al.
Publicado: (2023)

PReS-FINAL-2002: Adverse events during anti-TNF therapy in patients with JIA
por: Tarkiainen, M, et al.
Publicado: (2013)

Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use
por: Aalto, Kristiina, et al.
Publicado: (2017)

Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain
por: Backström, Maria, et al.
Publicado: (2023)

Finding specific cut-off values of JADAS-10 and JADAS3-10 for disease activity levels in juvenile idiopathic arthritis: a finnish multicenter study
por: Backström, Maria, et al.
Publicado: (2014)

Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis
por: Backström, Maria, et al.
Publicado: (2019)

Defining new clinically derived criteria for high disease activity in non-systemic juvenile idiopathic arthritis: a Finnish multicentre study
por: Backström, Maria, et al.
Publicado: (2018)

Disease characteristics of HLA-B27 positive and negative finnish patients with juvenile idiopathic arthritis - results of the 18-year cohort follow-up study
por: Peltoniemi, Suvi Oili Orvokki, et al.
Publicado: (2023)

The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial
por: Visvanathan, Sudha, et al.
Publicado: (2010)

Dimensions of Social Stratification and Their Relation to Mortality: A Comparison Across Gender and Life Course Periods in Finland
por: Hoffmann, Rasmus, et al.
Publicado: (2019)

Ongoing disease-activity and change in ILAR categories in a Nordic juvenile idiopathic arthritis cohort
por: Nordal, Ellen, et al.
Publicado: (2012)

Paediatric rheumatologists do not score the physician’s global assessment of juvenile idiopathic arthritis disease activity in the same way
por: Backström, Maria, et al.
Publicado: (2023)

Long-term trends in urban-neighbourhood inequalities in cause-specific mortality and hospitalisation – multilevel analyses among individuals nested in Finnish post-code areas, 1991–2018
por: Tarkiainen, Lasse, et al.
Publicado: (2022)

The contribution of health policy and care to income differences in life expectancy – a register based cohort study
por: Manderbacka, Kristiina, et al.
Publicado: (2013)

The changing contribution of childhood social characteristics to mortality: a comparison of Finnish cohorts born in 1936–50 and 1961–75
por: Martikainen, Pekka, et al.
Publicado: (2020)

Transitioning patients with juvenile idiopathic arthritis to adult care: the Nordic experience
por: Mikola, Katriina, et al.
Publicado: (2022)

Lethal chickenpox infection during treatment with infliximab and methotrexate
por: Estmann, A, et al.
Publicado: (2011)

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
por: Baranauskaite, Asta, et al.
Publicado: (2011)

Changes in regional variation in mortality over five decades – The contribution of age and socioeconomic population composition
por: Suulamo, Ulla, et al.
Publicado: (2021)

Income differences in partial life expectancy between ages 35 and 64 from 1988 to 2017: the contribution of living arrangements
por: Knop, Jade, et al.
Publicado: (2022)

The impact of income definitions on mortality inequalities
por: Shi, Jiaxin, et al.
Publicado: (2021)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
por: Dénarié, Delphine, et al.
Publicado: (2017)

Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
por: Akhlaghi, Saeed, et al.
Publicado: (2019)

Infliximab/methotrexate/methylprednisolone: COVID-19 infection: 2 case reports
Publicado: (2020)

Osteochondral lesions in children with juvenile idiopathic arthritis
por: Kröger, Liisa, et al.
Publicado: (2013)

Time-varying effects of socio-demographic and economic factors on the use of institutional long-term care before dementia-related death: A Finnish register-based study
por: Korhonen, Kaarina, et al.
Publicado: (2018)

Midlife socioeconomic position and old-age dementia mortality: a large prospective register-based study from Finland
por: Korhonen, Kaarina, et al.
Publicado: (2020)

Childhood socio-economic circumstances and dementia: prospective register-based cohort study of adulthood socio-economic and cardiovascular health mediators
por: Korhonen, Kaarina, et al.
Publicado: (2022)

Early treatment with infliximab in patients with juvenile idiopathic arthritis
por: Sleptsova, TV, et al.
Publicado: (2011)

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
por: Ruperto, Nicolino, et al.
Publicado: (2009)

Infliximab in ankylosing spondylitis: alone or in combination with methotrexate? A pharmacokinetic comparative study
por: Mulleman, Denis, et al.
Publicado: (2011)

The Impact of Unemployment on Antidepressant Purchasing: Adjusting for Unobserved Time-constant Confounding in the g-Formula
por: Bijlsma, Maarten J., et al.
Publicado: (2019)

Exploring the longevity advantage of doctorates in Finland and Sweden: The role of smoking- and alcohol-related causes of death
por: Junna, Liina M., et al.
Publicado: (2020)

Juvenile Arthritis Disease Activity Score (JADAS) based on CRP; validity and predictive ability in a Nordic population-based setting
por: Nordal, EB, et al.
Publicado: (2011)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis
por: Tynjälä, P, et al.
Publicado: (2008)

Contribution of smoking and alcohol consumption to income differences in life expectancy: evidence using Danish, Finnish, Norwegian and Swedish register data
por: Östergren, Olof, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aloddpadr4s1q6cgvmlvg8s4fc